Showing results (1-10 of 96) with videos related to
Sort By:
Pageof 10
Diabetes & Vascular Disease Research|June 22, 2012
Statins and beyond: concurrent strategies for prevention of cardiovascular disease in patients with type 2 diabetesEberhard StandlDiabetes Research and Clinical Practice|February 10, 2020
Treatment paradigm shifting implications of recent cardiovascular outcome trials: Core insights on the brink of the 2020iesEberhard Standl, Oliver SchnellEndocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|April 22, 2006
Impaired glucose tolerance, diabetes, and cardiovascular diseaseOliver Schnell, Eberhard StandlDiabetes Research and Clinical Practice|April 8, 2021
Heart failure outcomes and Covid-19Eberhard Standl, Oliver SchnellCells|April 25, 2025
Increased Risk of Cancer-An Integral Component of the Cardio-Renal-Metabolic Disease Cluster and Its ManagementEberhard Standl, Oliver SchnellDiabetes & Vascular Disease Research|April 18, 2012
Alpha-glucosidase inhibitors 2012 - cardiovascular considerations and trial evaluationEberhard Standl, Oliver SchnellBest Practice & Research. Clinical Endocrinology & Metabolism|June 13, 2009
The impact of glucose-lowering therapy on cardiovascular outcomesEberhard Standl, Martin Müller, Oliver SchnellCardiology and Therapy|August 20, 2014
Glycemic control: a combination of lifestyle management and the use of drugsEberhard Standl, Michael Erbach, Oliver SchnellDiabetes Technology & Therapeutics|January 5, 2005
The 12-month efficacy and safety of insulin detemir and NPH insulin in basal-bolus therapy for the treatment of type 1 diabetesEberhard Standl, Hanne Lang, Anthony RobertsPageof 10